GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » Short-Term Debt

Embecta (FRA:JX7) Short-Term Debt : €9 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Embecta Short-Term Debt?

Embecta's Short-Term Debt for the quarter that ended in Dec. 2024 was €9 Mil.

Embecta's quarterly Short-Term Debt declined from Jun. 2024 (€9 Mil) to Sep. 2024 (€9 Mil) but then increased from Sep. 2024 (€9 Mil) to Dec. 2024 (€9 Mil).

Embecta's annual Short-Term Debt declined from Sep. 2022 (€10 Mil) to Sep. 2023 (€9 Mil) and declined from Sep. 2023 (€9 Mil) to Sep. 2024 (€9 Mil).


Embecta Short-Term Debt Historical Data

The historical data trend for Embecta's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Short-Term Debt Chart

Embecta Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Short-Term Debt
Get a 7-Day Free Trial - - 9.60 8.90 8.56

Embecta Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.71 8.74 8.83 8.56 9.07

Embecta Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Embecta Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Embecta's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Embecta Business Description

Traded in Other Exchanges
Address
300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Embecta Headlines

No Headlines